Log in

Circassia Group Plc (CIR.L) Share Forecast, Price & News

GBX 21.66
-0.14 (-0.64 %)
(As of 10/30/2020 05:29 PM ET)
Today's Range
Now: GBX 21.66
50-Day Range
MA: GBX 25.12
52-Week Range
Now: GBX 21.66
Volume230,934 shs
Average Volume2.54 million shs
Market Capitalization£86.06 million
P/E RatioN/A
Dividend YieldN/A
Circassia Group Plc, a specialty pharmaceutical company, focuses on the development and commercialization of respiratory products. It operates through three segments: NIOX, Chronic Obstructive Pulmonary Disease (COPD), and LungFit. The company markets NIOX and NIOX VERO for use in asthma diagnosis and management; Tudorza for the treatment of COPD; and Duaklir, a fixed-dose combination of the long-acting muscarinic antagonist aclidinium bromide and long-acting beta agonist formoterol fumarate, which is administered twice-daily through the breath actuated Pressair inhaler for the maintenance treatment of COPD. It is also developing LungFit, a portable ventilator-compatible system that utilizes an electric voltage to produce precise quantities of nitric oxide from the nitrogen and oxygen in air. The company markets its products directly to specialists in the United States, the United Kingdom, China, Italy, and Germany, as well as through a network of partners internationally. Circassia Group Plc has a collaboration agreement with AstraZeneca to promote Tudorza and Duaklir for COPD treatment; and the United States and Chinese commercial rights to LungFit. The company was formerly known as Circassia Pharmaceuticals plc and changed its name to Circassia Group Plc in May 2020. Circassia Group Plc was founded in 2006 and is headquartered in Oxford, the United Kingdom.
Read More
Circassia Group Plc (CIR.L) logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.56 out of 5 stars

Industry, Sector and Symbol

Industry Biotechnology
Phone44 1865 405 560



Sales & Book Value

Annual Sales£55.20 million
Cash FlowGBX 2.60 per share
Book ValueGBX 19.90 per share



Market Cap£86.06 million
Next Earnings DateN/A
GBX 21.66
-0.14 (-0.64 %)
(As of 10/30/2020 05:29 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CIR News and Ratings via Email

Sign-up to receive the latest news and ratings for CIR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Circassia Group Plc (CIR.L) (LON:CIR) Frequently Asked Questions

How has Circassia Group Plc (CIR.L)'s stock been impacted by Coronavirus (COVID-19)?

Circassia Group Plc (CIR.L)'s stock was trading at GBX 19.65 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CIR stock has increased by 10.2% and is now trading at GBX 21.66.
View which stocks have been most impacted by COVID-19

How were Circassia Group Plc (CIR.L)'s earnings last quarter?

Circassia Group Plc (CIR.L) (LON:CIR) announced its quarterly earnings results on Thursday, September, 17th. The company reported ($3.00) earnings per share (EPS) for the quarter.
View Circassia Group Plc (CIR.L)'s earnings history

Who are some of Circassia Group Plc (CIR.L)'s key competitors?

What other stocks do shareholders of Circassia Group Plc (CIR.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Circassia Group Plc (CIR.L) investors own include EnQuest PLC (ENQ.L) (ENQ), boohoo group (BHOOY), Cummins (CMI), FutureFuel (FF), The Trade Desk (TTD), Ascential plc (ASCL.L) (ASCL), H&T Group (HAT), Howden Joinery Group Plc (HWDN.L) (HWDN), NMC Health (NMC) and Oxford BioMedica (OXB).

Who are Circassia Group Plc (CIR.L)'s key executives?

Circassia Group Plc (CIR.L)'s management team includes the following people:
  • Mr. Ian Roy Johnson, Exec. Chairman (Age 66, Pay $160k)
  • Mr. Jonathan Emms, COO & Exec. Director
  • Dr. Roderick Peter Hafner, Sr. VP of R&D (Age 54, Pay $360k)
  • Mr. Michael Roy David Roller A.C.A., BA (Hons), ACA, CFO & Director (Age 55)
  • Ms. Nina Kataria, Sr. VP Global HR

What is Circassia Group Plc (CIR.L)'s stock symbol?

Circassia Group Plc (CIR.L) trades on the London Stock Exchange (LON) under the ticker symbol "CIR."

How do I buy shares of Circassia Group Plc (CIR.L)?

Shares of CIR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Circassia Group Plc (CIR.L)'s stock price today?

One share of CIR stock can currently be purchased for approximately GBX 21.66.

How big of a company is Circassia Group Plc (CIR.L)?

Circassia Group Plc (CIR.L) has a market capitalization of £86.06 million and generates £55.20 million in revenue each year. Circassia Group Plc (CIR.L) employs 350 workers across the globe.

What is Circassia Group Plc (CIR.L)'s official website?

The official website for Circassia Group Plc (CIR.L) is www.circassia.co.uk.

How can I contact Circassia Group Plc (CIR.L)?

The company can be reached via phone at 44 1865 405 560.

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.